Adaptive Biotechnologies Corporation on April 7, 2023, Mark Adams, Chief Operating Officer was informed that his service is being terminated by May 2023. Julie Rubinstein, the Company's current President, will absorb the duties of the Chief Operating Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.59 USD | -0.55% | -5.53% | -26.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.73% | 532M | |
-31.06% | 9.3B | |
-8.43% | 3.1B | |
+27.31% | 2.87B | |
-14.31% | 2.17B | |
-18.94% | 1.75B | |
+73.13% | 1.5B | |
+30.25% | 807M | |
-1.97% | 759M | |
+5.17% | 313M |
- Stock Market
- Equities
- ADPT Stock
- News Adaptive Biotechnologies Corporation
- Adaptive Biotechnologies Corporation Announces Executive Changes